1. Home
  2. DCTH vs AVNW Comparison

DCTH vs AVNW Comparison

Compare DCTH & AVNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • AVNW
  • Stock Information
  • Founded
  • DCTH 1988
  • AVNW 2006
  • Country
  • DCTH United States
  • AVNW United States
  • Employees
  • DCTH N/A
  • AVNW N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • AVNW Radio And Television Broadcasting And Communications Equipment
  • Sector
  • DCTH Health Care
  • AVNW Technology
  • Exchange
  • DCTH Nasdaq
  • AVNW Nasdaq
  • Market Cap
  • DCTH 379.5M
  • AVNW 283.7M
  • IPO Year
  • DCTH N/A
  • AVNW 2007
  • Fundamental
  • Price
  • DCTH $11.94
  • AVNW $18.00
  • Analyst Decision
  • DCTH Strong Buy
  • AVNW Strong Buy
  • Analyst Count
  • DCTH 4
  • AVNW 5
  • Target Price
  • DCTH $21.50
  • AVNW $38.60
  • AVG Volume (30 Days)
  • DCTH 389.6K
  • AVNW 212.1K
  • Earning Date
  • DCTH 11-08-2024
  • AVNW 02-04-2025
  • Dividend Yield
  • DCTH N/A
  • AVNW N/A
  • EPS Growth
  • DCTH N/A
  • AVNW N/A
  • EPS
  • DCTH N/A
  • AVNW N/A
  • Revenue
  • DCTH $22,644,000.00
  • AVNW $409,603,000.00
  • Revenue This Year
  • DCTH $1,605.13
  • AVNW $9.06
  • Revenue Next Year
  • DCTH $111.67
  • AVNW $7.87
  • P/E Ratio
  • DCTH N/A
  • AVNW N/A
  • Revenue Growth
  • DCTH 945.91
  • AVNW 17.00
  • 52 Week Low
  • DCTH $3.10
  • AVNW $12.96
  • 52 Week High
  • DCTH $12.88
  • AVNW $38.85
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 63.93
  • AVNW 57.50
  • Support Level
  • DCTH $11.36
  • AVNW $17.27
  • Resistance Level
  • DCTH $12.10
  • AVNW $18.16
  • Average True Range (ATR)
  • DCTH 0.69
  • AVNW 0.75
  • MACD
  • DCTH 0.10
  • AVNW 0.50
  • Stochastic Oscillator
  • DCTH 84.97
  • AVNW 96.01

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

About AVNW Aviat Networks Inc.

Aviat Networks Inc is a networking solutions provider. It designs, manufactures, and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.

Share on Social Networks: